nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.031	0.031	CcSEcCtD
Darunavir—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0221	0.0221	CcSEcCtD
Darunavir—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0211	0.0211	CcSEcCtD
Darunavir—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0193	0.0193	CcSEcCtD
Darunavir—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0193	0.0193	CcSEcCtD
Darunavir—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0185	CcSEcCtD
Darunavir—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0172	CcSEcCtD
Darunavir—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0169	CcSEcCtD
Darunavir—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0168	CcSEcCtD
Darunavir—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0164	CcSEcCtD
Darunavir—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0164	CcSEcCtD
Darunavir—Gout—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0163	CcSEcCtD
Darunavir—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0161	0.0161	CcSEcCtD
Darunavir—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0155	CcSEcCtD
Darunavir—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0149	CcSEcCtD
Darunavir—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0137	CcSEcCtD
Darunavir—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0127	CcSEcCtD
Darunavir—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0127	CcSEcCtD
Darunavir—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0126	CcSEcCtD
Darunavir—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Darunavir—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0117	CcSEcCtD
Darunavir—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Darunavir—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Darunavir—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0113	CcSEcCtD
Darunavir—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0111	CcSEcCtD
Darunavir—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.011	0.011	CcSEcCtD
Darunavir—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Darunavir—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Darunavir—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0104	CcSEcCtD
Darunavir—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Darunavir—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Darunavir—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Darunavir—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00996	0.00996	CcSEcCtD
Darunavir—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00993	0.00993	CcSEcCtD
Darunavir—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00993	0.00993	CcSEcCtD
Darunavir—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00976	0.00976	CcSEcCtD
Darunavir—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00972	0.00972	CcSEcCtD
Darunavir—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00972	0.00972	CcSEcCtD
Darunavir—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00959	0.00959	CcSEcCtD
Darunavir—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00934	0.00934	CcSEcCtD
Darunavir—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00928	0.00928	CcSEcCtD
Darunavir—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00891	0.00891	CcSEcCtD
Darunavir—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00891	0.00891	CcSEcCtD
Darunavir—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0088	0.0088	CcSEcCtD
Darunavir—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00877	0.00877	CcSEcCtD
Darunavir—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00867	0.00867	CcSEcCtD
Darunavir—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00859	0.00859	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00842	0.00842	CcSEcCtD
Darunavir—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00837	0.00837	CcSEcCtD
Darunavir—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00835	0.00835	CcSEcCtD
Darunavir—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00833	0.00833	CcSEcCtD
Darunavir—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00833	0.00833	CcSEcCtD
Darunavir—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00828	0.00828	CcSEcCtD
Darunavir—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0081	0.0081	CcSEcCtD
Darunavir—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00801	0.00801	CcSEcCtD
Darunavir—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00776	0.00776	CcSEcCtD
Darunavir—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00763	0.00763	CcSEcCtD
Darunavir—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00759	0.00759	CcSEcCtD
Darunavir—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00751	0.00751	CcSEcCtD
Darunavir—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00735	0.00735	CcSEcCtD
Darunavir—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00721	0.00721	CcSEcCtD
Darunavir—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00708	0.00708	CcSEcCtD
Darunavir—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00674	0.00674	CcSEcCtD
Darunavir—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00664	0.00664	CcSEcCtD
Darunavir—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00654	0.00654	CcSEcCtD
Darunavir—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0065	0.0065	CcSEcCtD
Darunavir—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00638	0.00638	CcSEcCtD
Darunavir—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00616	0.00616	CcSEcCtD
Darunavir—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00614	0.00614	CcSEcCtD
Darunavir—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0061	0.0061	CcSEcCtD
Darunavir—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00607	0.00607	CcSEcCtD
Darunavir—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00599	0.00599	CcSEcCtD
Darunavir—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00596	0.00596	CcSEcCtD
Darunavir—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00595	0.00595	CcSEcCtD
Darunavir—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00594	0.00594	CcSEcCtD
Darunavir—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00587	CcSEcCtD
Darunavir—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00583	0.00583	CcSEcCtD
Darunavir—Cough—Hydrochlorothiazide—nephrolithiasis	0.00579	0.00579	CcSEcCtD
Darunavir—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00565	0.00565	CcSEcCtD
Darunavir—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00565	0.00565	CcSEcCtD
Darunavir—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00565	0.00565	CcSEcCtD
Darunavir—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00563	0.00563	CcSEcCtD
Darunavir—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00558	0.00558	CcSEcCtD
Darunavir—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00553	0.00553	CcSEcCtD
Darunavir—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00546	0.00546	CcSEcCtD
Darunavir—Shock—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00533	CcSEcCtD
Darunavir—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.0053	0.0053	CcSEcCtD
Darunavir—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00529	0.00529	CcSEcCtD
Darunavir—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00524	CcSEcCtD
Darunavir—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00516	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00494	0.00494	CcSEcCtD
Darunavir—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0049	0.0049	CcSEcCtD
Darunavir—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00487	0.00487	CcSEcCtD
Darunavir—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00483	0.00483	CcSEcCtD
Darunavir—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00482	0.00482	CcSEcCtD
Darunavir—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00477	0.00477	CcSEcCtD
Darunavir—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00471	CcSEcCtD
Darunavir—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00467	0.00467	CcSEcCtD
Darunavir—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00463	CcSEcCtD
Darunavir—Pain—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00463	CcSEcCtD
Darunavir—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00446	0.00446	CcSEcCtD
Darunavir—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00443	CcSEcCtD
Darunavir—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0043	0.0043	CcSEcCtD
Darunavir—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00428	0.00428	CcSEcCtD
Darunavir—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00428	0.00428	CcSEcCtD
Darunavir—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00399	0.00399	CcSEcCtD
Darunavir—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00389	CcSEcCtD
Darunavir—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00383	CcSEcCtD
Darunavir—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00371	0.00371	CcSEcCtD
Darunavir—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00358	CcSEcCtD
Darunavir—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00344	0.00344	CcSEcCtD
Darunavir—Rash—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00342	CcSEcCtD
Darunavir—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00341	CcSEcCtD
Darunavir—Headache—Hydrochlorothiazide—nephrolithiasis	0.00339	0.00339	CcSEcCtD
Darunavir—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00322	0.00322	CcSEcCtD
